Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Han M, Salamat A, Zhu L, et al. Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy. Mod Pathol. 2019;32:807–16.

    Article  Google Scholar 

  2. Moreno AC, Lin YH, Bedrosian I, Shen Y, Babiera GV, Shaitelman SF. Outcomes after treatment of metaplastic versus other breast cancer subtypes. J Cancer. 2020;11:1341–50.

    Article  Google Scholar 

  3. Zhao S, Ma D, Xiao Y, Jiang YZ, Shao ZM. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: a large population-based analysis. Eur J Surg Oncol. 2018;44:420–8.

    Article  Google Scholar 

  4. Tadros AB, Sevilimedu V, Giri DD, Zabor EC, Morrow M, Plitas G. Survival outcomes for metaplastic breast cancer differ by histologic subtype. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09430-5.

  5. Ng CKY, Piscuoglio S, Geyer FC, et al. The landscape of somatic genetic alterations in metaplastic breast carcinomas. Clin Cancer Res. 2017;23:3859–70.

    Article  CAS  Google Scholar 

  6. Joneja U, Vranic S, Swensen J, et al. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1. J Clin Pathol. 2017;70:255–9.

    Article  CAS  Google Scholar 

Download references

Funding

Funding was provided by “National Cancer Institute” Grant No: P30CA008748.

Author information

Authors and Affiliations

  1. Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Audree B. Tadros MD, MPH & George Plitas MD

Authors
  1. Audree B. Tadros MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Plitas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George Plitas MD.

Ethics declarations

George Plitas serves on the advisory boards of Merck and Tizona, has provided uncompensated services to Rubius Therapeutics and Takeda, and holds intellectual property rights in and has received research funding from Takeda. None of these relationships are related to the content of this study in any way. All other authors declare no financial or other interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tadros, A.B., Plitas, G. ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic Breast Cancer. Ann Surg Oncol 28, 4254–4255 (2021). https://doi.org/10.1245/s10434-020-09454-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09454-x

Search

Navigation